20 Jun 2024 Shaun Chilton is appointed Non-Executive Chairman of the Avacta Board of Directors Investors
23 May 2024 Successful Completion of First Cohort and Dosing of Three Patients of the Second Cohort in Arm 2 of Avacta’s AVA6000 Phase 1 trial Investors | Therapeutics